Back

Systematic review and meta-analysis comparing cardiac resynchronization therapy with versus without defibrillation in patients with non-ischemic cardiomyopathy

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Cardiac resynchronisation therapy - conduction system pacing 3 Cardiac Resynchronisation Therapy (CRT) EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Vanda Devesa Neto

Hospital Center Tondela Viseu, Viseu (Portugal)

7 More presentations in this session

Presentation thumbnail
Implant failure predictors of left bundle branch pacing used as cardiac resynchronization therapy: importance of left ventricular diameter and QRS morphology
Doctor F. Graterol Torres (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Optimising electrical performance of leadless cardiac resynchronisation therapy and leadless LV septal pacing
Doctor N. Wijesuriya (London, GB)
Abstract Slides Video
Presentation thumbnail
LVSP and LBBP result in similar or improved LV synchrony and hemodynamics compared to biventricular pacing
Mr L. Poviser (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Clinical impact of ICD implantation in octogenarians: a longitudinal cohort study
Doctor M. Spoladori (Parma, IT)
Abstract Slides Video
Presentation thumbnail
Absence of late gadolinium enhancement and outcomes of cardiac resynchronization therapy in non-ischemic dilated cardiomyopathy
Doctor A. Di Marco (Barcelona, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac resynchronisation therapy - conduction system pacing 3

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
CRT-P vs CRT-D in non-ischemic cardiomyopathy: still a matter of debate
thumbnail
Congress Presentation
Could ischemic etiology condemn patients to 'non-response' in cardiac resynchronization therapy?
thumbnail
Congress Presentation
Long-term outcomes of resynchronization therapy in heart failure patients with ischemic and non-ischemic cardiomyopathy. Single-centre experience.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources